Wyeth Loses Bid For Stay In Philly Fen-Phen Trial

Law360, Philadelphia (October 11, 2012, 3:19 PM EDT) -- A member of a nationwide class that agreed to settle multidistrict federal fen-phen litigation can pursue product liability claims in Pennsylvania state court after a judge there on Wednesday refused to stay an upcoming trial while drugmakers, including Wyeth Pharmaceuticals Inc., pursue an appeal.

Wyeth, a defendant in the suit along with Pfizer Inc., had asked the Philadelphia Court of Common Pleas to stay the trial while the companies petitioned the Third Circuit to overturn a federal court’s decision refusing to grant an injunction preventing the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.